Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Odelia, Amit"'
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 9, p 8126 (2023)
Chronic graft-versus-host disease (cGVHD) presents with dermal inflammation and fibrosis. We investigated the characteristics of extracellular vesicles (EVs) obtained from cGVHD patients, and their potential effects on human dermal fibroblast (NHDF)
Externí odkaz:
https://doaj.org/article/62ecb19da54144cfafe88b27a6b7af7e
Autor:
Israel Henig, Jonathan Isenberg, Dana Yehudai-Ofir, Ronit Leiba, Shimrit Ringelstein-Harlev, Ron Ram, Batia Avni, Odelia Amit, Sigal Grisariu, Tehila Azoulay, Ilana Slouzkey, Tsila Zuckerman
Publikováno v:
Vaccines, Vol 11, Iss 4, p 775 (2023)
COVID-19-related mortality among hematopoietic stem cell transplantation (HSCT) recipients in the pre-vaccine era ranged between 22 and 33%. The Pfizer/BioNTech BNT162b2 vaccine demonstrated significant immunogenicity and efficacy in the healthy popu
Externí odkaz:
https://doaj.org/article/94348d0ee029449fa530060c7aaf3ce8
Autor:
Ron Ram, Sigal Grisariu, Liat Shargian-Alon, Odelia Amit, Yaeli Bar-On, Polina Stepensky, Moshe Yeshurun, Batia Avni, David Hagin, Chava Perry, Ronit Gurion, Nadav Sarid, Yair Herishanu, Ronit Gold, Chen Glait-Santar, Sigi Kay, Irit Avivi
Publikováno v:
Haematologica, Vol 107, Iss 5 (2021)
Data regarding efficacy and toxicity of chimeric antigen receptor T (CAR-T) cell therapy in the elderly, geriatric population are insufficient. In 2019, tisagenlecleucel and axicabtagene-ciloleucel were commercially approved for relapsed/refractory d
Externí odkaz:
https://doaj.org/article/ee6304dbe547454693562f57a4f69b46
Autor:
Ofrat Beyar-Katz, Chava Perry, Yael Bar On, Odelia Amit, Odit Gutwein, Ofir Wolach, Rotem Kedar, Oleg Pikovsky, Irit Avivi, Ronit Gold, Jonathan Ben-Ezra, David Shasha, Ronen Ben Ami, Ron Ram
Publikováno v:
Annals of Hematology. 101:1769-1776
Anti CD-19 chimeric antigen receptor T (CAR-T) cells demonstrate effective early anti-tumor response; however, impaired hematopoietic recovery is observed in about 30% of patients with prolonged cytopenia appearing as an unmet need for optimal treatm
Autor:
Ron Ram, Christof Scheid, Odelia Amit, Jens Markus Chemnitz, Yakir Moshe, Michael Hallek, Dominik Wolf, Irit Avivi, Udo Holtick
Publikováno v:
Haematologica, Vol 104, Iss 9 (2019)
Primary refractory acute myeloid leukemia (AML) is associated with a dismal prognosis. The FLAMSA-reduced intensity conditioning protocol (total body irradiation or treosulfan-based) has been described as an effective approach in patients with refrac
Externí odkaz:
https://doaj.org/article/5444cf47b74342ef8a5f7f8ee1c0ece0
Autor:
Ofrat Beyar Katz, Chava Perry, Sigal Grisariu‐Greenzaid, Dana Yehudai‐Ofir, Efrat Luttwak, Batia Avni, Tsila Zuckerman, Inbal Sdayoor, Polina Stepensky, Shimrit Ringelstein‐Harlev, Yael Bar‐On, Diana Libster, Liat Sharvit, Odelia Amit, Uri Greenbaum, Ronit Gold, Yair Herishanu, Noam Benyamini, Irit Avivi, Ron Ram
Publikováno v:
European Journal of Haematology.
Autor:
Ron Ram, Odelia Amit, Amos Adler, Yael Bar On, Ofrat Beyar-Katz, Irit Avivi, David Shasha, Ronen Ben Ami
Background - The optimal duration and spectrum of empiric antimicrobial therapy of febrile neutropenia in patients after cellular therapy is unclear. Early de-escalation has been suggested by several groups, however studies exclusively focusing on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba6679fc3b4896e2baaa16a53f065641
https://doi.org/10.21203/rs.3.rs-2705124/v1
https://doi.org/10.21203/rs.3.rs-2705124/v1
Autor:
Irit Avivi, Chava Perry, Yafit Segman, Odelia Amit, Yaeli Bar-On, Ofrat Beyer Katz, Ronit Gold, Elena Ribakovsky, Abraham Avigdor, Vladimir Vainstein, Neta Goldschmidt, Shimrit Ringelstein-Harlev, Netanel A. Horowitz, Odit Gutwein, Ronit Gurion, Gilad Itchaki, Uri Abadi, Anatoly Nemets, Orit Sofer, Miri Vezker, Tamar Tadmor, Najib Dally, Kalman Filanovsky, Merav Leiba, Nadav Sarid, Noam Benyamini, Efrat Luttwak, Yair Herishanu, Ron Ram
Publikováno v:
Annals of Hematology. 101:755-762
Polatuzumab (Pola)-based regimens and chimeric antigen receptor T (CAR T) cells provide superior outcome compared to conventional chemoimmunotherapy in patients with relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL). Choosing between thes
Autor:
Ofrat Beyar-Katz, Chava Perry, Yael Bar-On, Sigal Grisariu, Dana Yehudai-Ofir, Efrat Luttwak, Batia Avni, Tsila Zuckerman, Inbal Sdayoor, Polina Stepensky, Shimrit Ringelstein-Harlev, Diana Libster, Liat Sharvit, Odelia Amit, Uri Greenbaum, Ronit Gold, Yair Herishanu, Noam Benyamini, Irit Avivi, Ron Ram
Chimeric antigen receptor T-cells (CAR-T) are widely used for the treatment of relapsed/refractory Diffuse large B cell lymphoma (DLBCL). The data for CAR-T cell therapy in patients with extra-nodal(EN) lymphoma is restricted. We included 126 consecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5855462c6ce33322e2ba406612a76c9f
https://doi.org/10.21203/rs.3.rs-2262627/v1
https://doi.org/10.21203/rs.3.rs-2262627/v1
Autor:
David Shasha, Chava Perry, Ron Ram, Noam Benyamini, Adrian Duek, Odelia Amit, Ofrat Beyar-Katz, Ronit Gold, Yael Bar On, Irit Avivi, Ronen Ben-Ami, Nino Kikozashvili, Yair Herishanu
Publikováno v:
European Journal of Haematology. 108:52-60
The characteristics of infections following chimeric antigen receptor T (CAR-T) cells targeting CD19 in real-word population are obscure. We analyzed infections' characteristics in the first month among consecutive patients with diffuse large B-cell